A citation-based method for searching scientific literature

David M Brown, Quan Dong Nguyen, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Patricio G Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G Rubio, Anthony P Adamis, Jason S Ehrlich, J Jill Hopkins. Ophthalmology 2013
Times Cited: 540







List of co-cited articles
736 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
41

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
883
36

Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Jeffrey S Heier, Jean-François Korobelnik, David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Edoardo Midena, David S Boyer, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2016
192
32

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Neil M Bressler, Susan B Bressler, Alexander J Brucker, Frederick L Ferris, G Robert Hampton, Chirag Jhaveri,[...]. Ophthalmology 2016
472
29

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller,[...]. Ophthalmology 2010
926
27

Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jeffrey S Heier, Edoardo Midena, Peter K Kaiser, Hiroko Terasaki, Dennis M Marcus,[...]. Ophthalmology 2014
465
25

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
24

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
883
23

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
David S Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K Maturi, Albert J Augustin, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup. Ophthalmology 2014
609
23

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Jose Garcia-Arumi, Francesco Bandello, Karina Berg, Usha Chakravarthy, Bianca S Gerendas, Jost Jonas, Michael Larsen, Ramin Tadayoni, Anat Loewenstein. Ophthalmologica 2017
245
21

Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, Szilárd Kiss, Anat Loewenstein, Albert J Augustin, Julia Ma, Allen C Ho, Vaishali Patel, Scott M Whitcup,[...]. Am J Ophthalmol 2016
171
19

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Frank G Holz, David S Boyer, Edoardo Midena, Jeffrey S Heier, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2015
303
19

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.
Pascale Massin, Francesco Bandello, Justus G Garweg, Lutz L Hansen, Simon P Harding, Michael Larsen, Paul Mitchell, Dianne Sharp, U E K Wolf-Schnurrbusch, Margarita Gekkieva,[...]. Diabetes Care 2010
478
17

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Sanford Chen, David Boyer, Jose Ruiz-Moreno, Bruce Garretson, Amod Gupta, Seenu M Hariprasad, Clare Bailey,[...]. Ophthalmology 2012
304
16

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Lee M Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N Antoszyk, Carl W Baker, Brian B Berger, Neil M Bressler, David Browning,[...]. JAMA 2015
397
15

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, Andrew N Antoszyk, David J Browning, Kakarla V Chalam, Sandeep Grover, Lee M Jampol, Chirag D Jhaveri, Michele Melia,[...]. JAMA 2019
102
13

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
Ranjan Rajendram, Samantha Fraser-Bell, Andrew Kaines, Michel Michaelides, Robin D Hamilton, Simona Degli Esposti, Tunde Peto, Catherine Egan, Catey Bunce, Richard David Leslie,[...]. Arch Ophthalmol 2012
253
12

One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.
Diana V Do, Quan Dong Nguyen, David Boyer, Ursula Schmidt-Erfurth, David M Brown, Robert Vitti, Alyson J Berliner, Bo Gao, Oliver Zeitz, Rene Ruckert,[...]. Ophthalmology 2012
256
12

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Raj K Maturi, Adam R Glassman, Danni Liu, Roy W Beck, Abdhish R Bhavsar, Neil M Bressler, Lee M Jampol, Michele Melia, Omar S Punjabi, Hani Salehi-Had,[...]. JAMA Ophthalmol 2018
104
12

Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.
Susan B Bressler, Allison R Ayala, Neil M Bressler, Michele Melia, Haijing Qin, Frederick L Ferris, Christina J Flaxel, Scott M Friedman, Adam R Glassman, Lee M Jampol,[...]. JAMA Ophthalmol 2016
98
12

Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.
Pedro Romero-Aroca, Marc Baget-Bernaldiz, Alicia Pareja-Rios, Maribel Lopez-Galvez, Raul Navarro-Gil, Raquel Verges. J Diabetes Res 2016
141
11

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
Neil M Bressler, Wesley T Beaulieu, Adam R Glassman, Kevin J Blinder, Susan B Bressler, Lee M Jampol, Michele Melia, John A Wells. JAMA Ophthalmol 2018
121
11

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.
Michel Michaelides, Andrew Kaines, Robin D Hamilton, Samantha Fraser-Bell, Ranjan Rajendram, Fahd Quhill, Christopher J Boos, Wen Xing, Catherine Egan, Tunde Peto,[...]. Ophthalmology 2010
329
11


Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab.
Nicholas Papadopoulos, Joel Martin, Qin Ruan, Ashique Rafique, Michael P Rosconi, Ergang Shi, Erica A Pyles, George D Yancopoulos, Neil Stahl, Stanley J Wiegand. Angiogenesis 2012
639
11


Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy: Long-Term Outcomes of the Phase III RIDE and RISE Trials.
David S Boyer, Quan Dong Nguyen, David M Brown, Karen Basu, Jason S Ehrlich. Ophthalmology 2015
94
10

Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Thomas Ciulla, David Boyer, Frank G Holz, Michael Tolentino, Amod Gupta, Lilianne Duarte, Steven Madreperla,[...]. Ophthalmology 2011
247
10

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.
Michael J Elman, Allison Ayala, Neil M Bressler, David Browning, Christina J Flaxel, Adam R Glassman, Lee M Jampol, Thomas W Stone. Ophthalmology 2015
223
10

Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
Jennifer K Sun, Michael M Lin, Jan Lammer, Sonja Prager, Rutuparna Sarangi, Paolo S Silva, Lloyd Paul Aiello. JAMA Ophthalmol 2014
236
10

Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.
Susan B Bressler, Haijing Qin, Roy W Beck, Kakarla V Chalam, Judy E Kim, Michele Melia, John A Wells. Arch Ophthalmol 2012
182
10

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
Ryan Lee, Tien Y Wong, Charumathi Sabanayagam. Eye Vis (Lond) 2015
578
10

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.
Quan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, Roomasa Channa, Elham Hatef, Diana V Do, David Boyer, Jeffery S Heier, Prema Abraham, Allen B Thach,[...]. Ophthalmology 2010
364
10

Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study.
Ursula Schmidt-Erfurth, Gabriele E Lang, Frank G Holz, Reinier O Schlingemann, Paolo Lanzetta, Pascale Massin, Ortrud Gerstner, Abdelkader Si Bouazza, Haige Shen, Aaron Osborne,[...]. Ophthalmology 2014
211
10

Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T.
Neil M Bressler, Wesley T Beaulieu, Maureen G Maguire, Adam R Glassman, Kevin J Blinder, Susan B Bressler, Victor H Gonzalez, Lee M Jampol, Michele Melia, Jennifer K Sun,[...]. Am J Ophthalmol 2018
41
24

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Danni Liu, Jennifer K Sun, Andrew N Antoszyk, Carl W Baker, Neil M Bressler, Michael J Elman, Frederick L Ferris, Thomas W Gardner,[...]. JAMA Ophthalmol 2018
156
10

Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.
Catharina Busch, Dinah Zur, Samantha Fraser-Bell, Inês Laíns, Ana Rita Santos, Marco Lupidi, Carlo Cagini, Pierre-Henry Gabrielle, Aude Couturier, Valérie Mané-Tauty,[...]. Acta Diabetol 2018
57
15

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.
David J Browning, Adam R Glassman, Lloyd Paul Aiello, Roy W Beck, David M Brown, Donald S Fong, Neil M Bressler, Ronald P Danis, James L Kinyoun, Quan Dong Nguyen,[...]. Ophthalmology 2007
391
9

Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
Peter A Campochiaro, Gulnar Hafiz, Syed Mahmood Shah, Steven Bloom, David M Brown, Miguel Busquets, Thomas Ciulla, Leonard Feiner, Nelson Sabates, Kathleen Billman,[...]. Ophthalmology 2010
96
9

Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
Joan-En Chang-Lin, Mayssa Attar, Andrew A Acheampong, Michael R Robinson, Scott M Whitcup, Baruch D Kuppermann, Devin Welty. Invest Ophthalmol Vis Sci 2011
348
9


A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
Mark C Gillies, Lyndell L Lim, Anna Campain, Godfrey J Quin, Wedad Salem, Ji Li, Stephanie Goodwin, Christine Aroney, Ian L McAllister, Samantha Fraser-Bell. Ophthalmology 2014
184
9

Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year Outcomes.
John F Payne, Charles C Wykoff, W Lloyd Clark, Beau B Bruce, David S Boyer, David M Brown. Ophthalmology 2017
50
18

Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Susan B Bressler, Danni Liu, Adam R Glassman, Barbara A Blodi, Alessandro A Castellarin, Lee M Jampol, Paul L Kaufman, Michele Melia, Harinderjit Singh, John A Wells. JAMA Ophthalmol 2017
86
10

ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data.
Pravin U Dugel, Joanna H Campbell, Szilárd Kiss, Anat Loewenstein, Vanessa Shih, Xiaoshu Xu, Nancy M Holekamp, Albert J Augustin, Allen C Ho, Victor H Gonzalez,[...]. Retina 2019
29
27

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.
Matias Iglicki, Catharina Busch, Dinah Zur, Mali Okada, Miriana Mariussi, Jay Kumar Chhablani, Zafer Cebeci, Samantha Fraser-Bell, Voraporn Chaikitmongkol, Aude Couturier,[...]. Retina 2019
90
8

The association between percent disruption of the photoreceptor inner segment-outer segment junction and visual acuity in diabetic macular edema.
Anjali S Maheshwary, Stephen F Oster, Ritchie M S Yuson, Lingyun Cheng, Francesca Mojana, William R Freeman. Am J Ophthalmol 2010
200
8


A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.
Ingrid U Scott, Allison R Edwards, Roy W Beck, Neil M Bressler, Clement K Chan, Michael J Elman, Scott M Friedman, Craig Michael Greven, Raj K Maturi, Dante J Pieramici,[...]. Ophthalmology 2007
322
8

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1).
Kevin J Blinder, Pravin U Dugel, Sanford Chen, J Michael Jumper, John G Walt, David A Hollander, Lanita C Scott. Clin Ophthalmol 2017
69
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.